glp 1 agonists microdose Microdosing of GLP-1's / Wellness Services / Services Microdosing GLP-1: A New Approach
Description
The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE -/- and LDLr -/- mice by a mechanism that includes inflammatory pathways
This means: They underwent extensive clinical trials Dosing, purity, and manufacturing are strictly regulates Safety and efficacy were evaluated in thousands of patients The formulation is standardized and consistent FDA approval ensures that what you are receiving has been rigorously tested for both safety and predictable results
A meta-analysis of clinical studies indicated that treatment with GLP-1RAs of obese patients with T2MD did not increase the risk of breast tumors, nor did it increase the risk of acute pancreatitis, pancreatic cancer, and overall tumor neoplasia (207209)
With such an eminent authority leading the experiments no one at the time thought to question the results
